Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of a novel prognostic signature and key genes related to development of anaplastic thyroid carcinoma. | Discov Oncol | 2024 | 39562412 | PubTator, text mining | PubMed |
| Bioinformatics-based screening of hub genes for prostate cancer bone metastasis and analysis of immune infiltration. | Medicine (Baltimore) | 2024 | 39560511 | PubTator, text mining | PubMed |
| Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis. | Medicine (Baltimore) | 2024 | 39470543 | PubTator, text mining | PubMed |
| Establishment and validation of the prognostic risk model based on the anoikis-related genes in esophageal squamous cell carcinoma. | Ann Med | 2024 | 39444152 | PubTator, text mining | PubMed |
| Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations. | Front Immunol | 2024 | 39391317 | PubTator, text mining | PubMed |
| The single-cell transcriptome of mTECs and CD4+ thymocytes under adhesion revealed heterogeneity of mTECs and a network controlled by Aire and lncRNAs. | Front Immunol | 2024 | 39328409 | PubTator, text mining | PubMed |
| Elucidating the molecular interactions and immune modulation of bisphenols exposure in the pathogenesis of polycystic ovary syndrome. | Reprod Toxicol | 2024 | 39313041 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma. | Genet Res (Camb) | 2024 | 39297018 | PubTator, text mining | PubMed |
| Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis. | Clin Cosmet Investig Dermatol | 2024 | 39258216 | PubTator, text mining | PubMed |
| Enhancing metastatic colorectal cancer prediction through advanced feature selection and machine learning techniques. | Int Immunopharmacol | 2024 | 39226823 | PubTator, text mining | PubMed |
| Expression of Concern: T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma. | Mol Oncol | 2024 | 39171943 | PubTator, text mining | PubMed |
| Exploring New Frontiers: Innovations and Therapeutic Targets in Dermatology. | Int J Mol Sci | 2024 | 39125670 | PubTator, text mining | PubMed |
| The oncogenic kinase TOPK upregulates in psoriatic keratinocytes and contributes to psoriasis progression by regulating neutrophils infiltration. | Cell Commun Signal | 2024 | 39090602 | PubTator, text mining | PubMed |
| DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma. | Cancer Med | 2024 | 39087856 | PubTator, text mining | PubMed |
| Diminazene aceturate inhibits the SARS-CoV-2 spike protein-induced inflammation involving leukocyte migration and DNA extracellular traps formation. | Life Sci | 2024 | 38986896 | PubTator, text mining | PubMed |
| WZ-3146 acts as a novel small molecule inhibitor of KIF4A to inhibit glioma progression by inducing apoptosis. | Cancer Cell Int | 2024 | 38937742 | PubTator, text mining | PubMed |
| SPIKENET: An Evidence-Based Therapy for Long COVID. | Viruses | 2024 | 38932130 | PubTator, text mining | PubMed |
| TOPK Inhibition Enhances the Sensitivity of Colorectal Cancer Cells to Radiotherapy by Reducing the DNA Damage Response. | Curr Med Sci | 2024 | 38900386 | PubTator, text mining | PubMed |
| TransExION: a transformer based explainable similarity metric for comparing IONS in tandem mass spectrometry. | J Cheminform | 2024 | 38807166 | PubTator, text mining | PubMed |
| Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy. | Sci Rep | 2024 | 38755218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=6